ChEMBL ID: CHEMBL4297833
Mechanism of action: Lymphocyte differentiation antigen CD38 binding agent
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Trials and conditions connected to MEZAGITAMAB